Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-17
2007-07-17
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S496000
Reexamination Certificate
active
11129207
ABSTRACT:
A compound of formula I:or solvate thereof, wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically acceptable cation.
REFERENCES:
patent: 4464467 (1984-08-01), Hatori et al.
patent: 4508647 (1985-04-01), Hatori et al.
patent: 2003/0120069 (2003-06-01), Thurston et al.
patent: 1 193 270 (2003-05-01), None
patent: 58180487 (1983-10-01), None
patent: WO 93/18045 (1993-09-01), None
patent: WO 00/12508 (2000-03-01), None
Alley et al.,Proc. Amer. Cancer Res., 43, (#315), 63 (2002).
Berge et al.,J. Pharm. Sci., 66(1), 1-19 (1977).
Bose et al.,Tetrahedron, 48(4), 751-758 (1992).
Gregson et al.,Chem. Commun., 9, 797-798 (1999).
Gregson et al.,J. Med. Chem., 44(5), 737-748 (2001).
Gregson et al.,J. Med. Chem., 47(5), 1161-1174 (2004).
Hartley et al.,Proc. Amer. Assoc. Cancer Res., 43, (#2432), 489 (2002).
Hurley et al.,Acc. Chem. Res., 19, 230-237 (1986).
Kohn,Antibiotics, 3, 3-11 (1975).
Leimgruber et al.,J. Am. Chem. Soc., 87, 5791-5793 (1965).
Leimgruber et al.,J. Am. Chem. Soc., 87, 5793-5795 (1965).
Mountzouris et al.,J. Med. Chem., 37(19), 3132-3140 (1994).
Smellie et al.,Br. J. Cancer, 70, 48-53 (1994).
Thurston et al.,Chem. Rev., 1994, 433-465 (1994).
Walton et al.,Cancer Chemother. Pharmacol., 38, 431-438 (1996).
Arima et al.,J. Antibiotics, 25(8), 437-444 (1972).
Hara et al.,J. Antibiotics, 41(5), 702-704 (1988).
Hochlowski et al.,J. Antibiotics, 40(2), 145-148 (1987).
Itoh et al.,J. Antibiotics, 41(9), 1281-1284 (1988).
Konishi et al.,J. Antibiotics., 37(3), 200-206 (1984).
Kuminoto et al.,J. Antibiotics, 33(6), 665-667 (1980).
Langley et al.,J. Org. Chem., 52(1), 91-97 (1987).
Leber et al.,J. Am. Chem. Soc., 110(9), 2992-2993 (1988).
Sagnou et al.,Bioorg. Med. Chem. Lett., 10, 2083-2086 (2000).
Shimizu et al.,J. Antibiotics, 35(8), 972-978 (1982).
Takeuchi et al.,J. Antibiotics, 29(1), 93-96 (1976).
Thurston et al.,Chem. Brit., 26, 767-772 (1990).
Thurston et al.,J. Org. Chem., 61(23), 8141-8147 (1996).
Tsunakawa et al.,J. Antibiotics, 41, 1366-1373 (1988).
Turner et al., 37th Midwest Regional Meeting of the American Chemical Society, Abstract, Oct. 23-25, 2002.
Gregson Stephen
Howard Philip
Liu Paul S.
Snader Kenneth M.
Thurston David E.
Kifle Bruck
Leydig , Voit & Mayer, Ltd.
Spirogen, Ltd.
United States of America, Represented by the Secretary, Departme
LandOfFree
Pyrrolobenzodiazepines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolobenzodiazepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolobenzodiazepines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3783372